Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis

Fig. 1

Expression of CPB2 (TAFI) and THBD (thrombomodulin) mRNA in breast cancer cell lines. RNA was extracted from various breast cancer cell lines and expression of CPB2 and THBD was analyzed using qRT-PCR. Expression of CPB2 and THBD were normalized to GAPDH mRNA levels in all cells. The data are expressed relative to THP-1 macrophages (CPB2) or HUVECs (THBD) and are the means ± SEM of 3–4 independent experiments, and are arranged in decreasing order of THBD expression from left to right. *: p <0.05 versus MCF10A (CPB2) and †: p <0.05 versus MCF10A (THBD)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us